Page last updated: 2024-08-23

fagaronine and Leukemia L 1210

fagaronine has been researched along with Leukemia L 1210 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Khara, S; Charpentier, E; Devy, J; Duval, O; Helesbeux, JJ; Letinois, I; Martiny, L; Ouchani, F; Oudot, C; Rabenoelina, F; Salesse, S; Vanquelef, E1
Bisagni, E; Croisy, A; Janin, YL; Riou, JF1

Other Studies

2 other study(ies) available for fagaronine and Leukemia L 1210

ArticleYear
The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.
    Investigational new drugs, 2011, Volume: 29, Issue:5

    Topics: Alkaloids; Animals; Aprotinin; Benzophenanthridines; Cell Death; Cell Proliferation; Dipeptides; Down-Regulation; Enzyme Activation; Fibrinolysin; Gelatinases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Leukemia L1210; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Neoplasm Invasiveness; Plasminogen Activators

2011
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.
    Journal of medicinal chemistry, 1993, Nov-12, Volume: 36, Issue:23

    Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Benzophenanthridines; Breast Neoplasms; Humans; Leukemia L1210; Leukemia P388; Mice; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1993